Remedica signed a Memorandum of Understanding (MoU) with the University of Nicosia in a ceremony held on the 30th of May 2025 at the University’s…

A new era begins for Remedica with the appointment of new CEO, Andrew Bird, signalling a renewed focus on global expansion, operational excellence, and long-term…

Remedica has signed a non-binding memorandum of understanding (MoU) with AJA Pharma, a subsidiary of Saudi Chemical Company Holding (SCCH), during CPHI Milan, marking the beginning of a…

CPHI Milan, the world’s leading pharmaceutical event, has concluded, bringing together top professionals from the healthcare and pharmaceutical sectors, all united by a shared mission…

From 8-10 October 2024 our team will be attending the upcoming CPHI event in Milan, one of the largest and most influential gatherings in the…

At Remedica we strongly believe that access to healthcare is a fundamental human right. That’s why we are proud to collaborate with Non-Governmental Organisations (NGOs)…

Remedica is proud to have recently achieved Pharmaceutical Supply Chain Initiative (PSCI) Partner status. The PSCI is an association of global pharmaceutical and healthcare companies…

We are thrilled to announce that we have signed a new contract with our business partner, EuroCons Group, to support our innovative project “Factory in…

Our cosmetic product, RemAthlon muscle Spray, was the Name Sponsor of the 5KM City Race at Limassol Marathon, which took place along the city’s coastal…

Remedica participated at EuroPLX84, the premier marketplace for Pharma Business Opportunities, which took place in Lisbon, Portugal, on 26-27 February 2024. Our team engaged in…